Stockscreener 앱 받기
6.61
0.00%
0.00
시간 외 거래:
6.61
전일 마감가:
$6.61
열려 있는:
$6.605
하루 거래량:
981.20K
Relative Volume:
0.32
시가총액:
$716.49M
수익:
$42.51M
순이익/손실:
$-116.49M
주가수익비율:
-5.9018
EPS:
-1.12
순현금흐름:
$-120.82M
1주 성능:
+1.23%
1개월 성능:
+15.96%
6개월 성능:
+118.15%
1년 성능:
-25.81%
1일 변동 폭
$6.33
$6.74
1주일 범위
$6.205
$7.07
52주 변동 폭
$1.03
$12.02
Tango Therapeutics Inc Stock (TNGX) Company Profile
명칭
Tango Therapeutics Inc
전화
(857) 320-4900
주소
201 BROOKLINE AVENUE, BOSTON
TNGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.61 | 704.56M | 42.51M | -116.49M | -120.82M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-17 | 개시 | Jefferies | Buy |
| 2024-04-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-12 | 개시 | Piper Sandler | Overweight |
| 2023-12-08 | 개시 | B. Riley Securities | Buy |
| 2022-10-20 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | 개시 | SVB Leerink | Outperform |
모두보기
Tango Therapeutics Inc 주식(TNGX)의 최신 뉴스
How moving averages guide Tango Therapeutics Inc. tradingFree Low Risk Picks for Daily Trading - Newser
What’s next for Tango Therapeutics Inc. stock priceShort-Term Market Movement Forecast Report - Newser
Tango Therapeutics Inc. recovery potential after sell offDaily Market Momentum and Pressure Analysis - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Watch With Alerts - Newser
What Fibonacci levels say about Tango Therapeutics Inc. reboundFree Short Term Buy List With Stop Protection - Newser
How high can Tango Therapeutics Inc. stock price go in 2025Trend Reversal Watch with Entry Signals - Newser
Advanced analytics toolkit walkthrough for Tango Therapeutics Inc.Buy Strategy Tracker with Growth Indicators - Newser
Will Tango Therapeutics Inc. see short term momentumSafe Entry Strategy with High Win Rate - Newser
Cantor Fitzgerald Issues Positive Forecast for TNGX Earnings - Defense World
Full technical analysis of Tango Therapeutics Inc. stockFree Strong Buy With Technical Confidence - Newser
Price action breakdown for Tango Therapeutics Inc.Volume Spike Detection for Early Breakouts - Newser
Wedbush Forecasts Stronger Earnings for Tango Therapeutics - Defense World
What machine learning models say about Tango Therapeutics Inc.Safe Entry Screening with Data Backed Analysis - Newser
Tango Therapeutics: Guggenheim Raises PT to $10, Maintains Buy Rating - AInvest
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tango Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Bank of New York Mellon Corp Acquires 10,213 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Tango Therapeutics 2025 Q2 Earnings Misses Targets as Net Loss Widens 52% - AInvest
Tango Therapeutics Reports Q2 2025 Financial Results - TipRanks
Tango (TNGX) Q2 Revenue Drops 52% - The Globe and Mail
Tango (TNGX) Q2 Revenue Drops 52% - The Motley Fool
Revolution Medicines shares rise 2.80% intraday after Tango Therapeutics reported dosing first patient in combination trial with Revolution Medicines RAS(ON) inhibitors. - AInvest
Navigating the Crossroads: Tango Therapeutics' Financial Resilience and the Road to Long-Term Value Creation - AInvest
Tango Therapeutics earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Tango Therapeutics earnings matched, revenue fell short of estimates - Investing.com
Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times
Tango Therapeutics, Inc. SEC 10-Q Report - TradingView
Tango Therapeutics Q2 revenue drops, net loss widens - MarketScreener
Analyzing Tango Therapeutics Inc. with risk reward ratio chartsLong Term Equity Screener with Safety Metrics - Newser
Technical Charts Suggest Momentum Shift in Tango Therapeutics Inc.Trend Analysis for Safer Trades Gains Popularity - metal.it
Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely? - Yahoo Finance
Is Tango Therapeutics Inc. stock bottoming outSmart Trade Forecast Based on Neural Logic - Newser
Can Tango Therapeutics Inc. stock recover from recent declinePredictable Income Summary for Long-Term Trades - Newser
Should I hold or sell Tango Therapeutics Inc. stock in 2025Build a portfolio that outperforms the market - Jammu Links News
Applying Elliott Wave Theory to Tango Therapeutics Inc.Smart Entry Signals for Active Traders - Newser
Published on: 2025-08-04 03:00:28 - Jammu Links News
How volatile is Tango Therapeutics Inc. stock compared to the marketInvest smarter with daily trading signals - Jammu Links News
What is the risk reward ratio of investing in Tango Therapeutics Inc. stockGet alerts on high-potential stock breakouts - Jammu Links News
What are the latest earnings results for Tango Therapeutics Inc.Explosive capital appreciation - Jammu Links News
Will Tango Therapeutics Inc. outperform the marketFree Capital Preserving Trade Plan Templates - Newser
How does Tango Therapeutics Inc. compare to its industry peersRealize exceptional returns through smart trading - Jammu Links News
What institutional investors are buying Tango Therapeutics Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
Does Tango Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven stock picks - Jammu Links News
What are Tango Therapeutics Inc. company’s key revenue driversInvest smarter with data-backed insights - Jammu Links News
How does Tango Therapeutics Inc. generate profit in a changing economyBuild your wealth with consistent stock growth - Jammu Links News
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN
What candlestick patterns are forming on Tango Therapeutics Inc.Free Consistent Profit Pattern Recognition Tools - Newser
Tango Therapeutics Inc (TNGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):